Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis
Open Access
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 40 (6) , 564-566
- https://doi.org/10.1136/ard.40.6.564
Abstract
The deposition of gold in the cornea—ocular chrysiasis—is a normal event during chrysotherapy. It may reflect tissue deposition of gold and be of value in predicting clinical improvement or toxic reactions. We studied 21 patients with rheumatoid arthritis on chrysotherapy but could find no relationship between the appearance of ocular chrysiasis, clinical improvement, and toxicity.This publication has 14 references indexed in Scilit:
- Epithelial Deposition of Gold in the Cornea in Patients Receiving Systemic TherapyAmerican Journal of Ophthalmology, 1979
- Ocular chrysiasis correlated with gold concentrations in the crystalline lens during chrysotherapyArthritis & Rheumatism, 1978
- CYCLOPHOSPHAMIDE, GOLD AND PENICILLAMINE—DISEASE-MODIFYING DRUGS IN RHEUMATOID ARTHRITIS—TAILORED DOSAGE AND ULTIMATE SUCCESSRheumatology, 1976
- Myelotoxicity of gold.BMJ, 1976
- The Quantitative Distribution Of Gold In Skin During ChrysotherapyJournal of Investigative Dermatology, 1975
- Significance of eosinophilia during gold therapyArthritis & Rheumatism, 1974
- Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.Annals of the Rheumatic Diseases, 1974
- Gold concentrations in hair, nail, and skin during chrysotherapyArthritis & Rheumatism, 1974
- Corneal chrysiasis. A clinical study in rheumatoid arthritis patients receiving gold therapyArthritis & Rheumatism, 1972
- Ocular ChrysiasisArchives of Ophthalmology (1950), 1956